HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Almay Milk Plus Skin Care To Drink In $28 Mil. At Retail, Revlon Predicts

This article was originally published in The Rose Sheet

Executive Summary

Almay will re-emphasize its skin care heritage with the December introduction of six-SKU Milk Plus, the Revlon company said. The line, introduced at the National Association of Chain Drug Stores Marketplace convention in New Orleans June 25-28, is expected to generate $28 mil. in retail consumption.

You may also be interested in...



Almay Kinetin Anti-Aging Launch Marks Ingredient's Mass Debut

Almay expects its new Kinetin Skincare Advanced Anti-Aging Series will attract department store shoppers to the mass brand, Exec VP and General Manager Vanessa Solomon said. Slated to launch globally in June, the seven-SKU line will be the first skin care offering in the U.S. mass market to contain the antioxidant ingredient.

Almay Kinetin Anti-Aging Launch Marks Ingredient's Mass Debut

Almay expects its new Kinetin Skincare Advanced Anti-Aging Series will attract department store shoppers to the mass brand, Exec VP and General Manager Vanessa Solomon said. Slated to launch globally in June, the seven-SKU line will be the first skin care offering in the U.S. mass market to contain the antioxidant ingredient.

Almay New Products To Increase Brand Sales 8%-12% In 2001

Almay product introductions in 2001 will fuel an 8%-12% increase in brand sales, Almay Exec VP and General Manager Vanessa Solomon predicted during a Revlon investor presentation Feb. 26.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008151

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel